| Literature DB >> 31286439 |
Miryam Cannizzaro1, Jana Jarošová1, Boel De Paepe2.
Abstract
The solute carrier (SLC) group of membrane transport proteins is crucial for cells via their control of import and export of vital molecules across the cellular membrane. Defects in these transporters with narrow substrate specificities cause monogenic disorders, giving us essential clues of their precise roles in cellular functioning. The SLC5 family in particular has been linked to various human diseases, of mild and severe phenotype as well as high and low prevalence. In this review, we describe the effects on health of SLC5 dysfunction and dysregulation by summarizing findings in patients with transporter gene defects. Patients display a plethora of pathologies which include glucose/galactose malabsorption, familiar renal glycosuria, thyroid dyshormonogenesis, and distal hereditary motor neuronopathies. In addition, the therapeutic potential of intervening in transporter activities for treating common diseases such as diabetes and cancer is explored.Entities:
Keywords: Cancer; Diabetes; Glucose/galactose malabsorption; Sodium glucose cotransporters; Solute carriers
Mesh:
Substances:
Year: 2019 PMID: 31286439 DOI: 10.1007/s13353-019-00502-1
Source DB: PubMed Journal: J Appl Genet ISSN: 1234-1983 Impact factor: 3.240